Sangamo: Q1 Earnings Snapshot

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Thursday reported a loss of $49.1 million in its first quarter.

On a per-share basis, the Brisbane, California-based company said it had a loss of 27 cents.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The drug developer posted revenue of $481,000 in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $8.5 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SGMO at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up